In inadequately controlled patients with Type 2 diabetes, Biphasic Insulin Aspart 30 combined with Pioglitazone provides better glycaemic control than Biphasic Insulin Aspart 30 monotherapy or Pioglitazone/Sulphonylurea combination.

被引：0

作者：

Raz, I

Stranks, S

Filipczak, R

Joshi, P

Lertoft, B

Råstam, J

Chow, FC

机构：

[1] Hadassah Hebrew Univ Hosp, Diabet Unit, Jerusalem, Israel

[2] Repatriat Gen Hosp, Daw Pk, Australia

[3] NZOZ Gadent, Diabet Unit, Rawa Mazowiecka, Poland

[4] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark

[5] Prince Wales Hosp, Diabet & Endocrine Ctr, Shatin, Hong Kong, Peoples R China

来源：

DIABETOLOGIA | 2003年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A8 / A8

页数：1

共 50 条

[1] In inadequately controlled patients with type 2 diabetes, Biphasic Insulin Asparti 30 combined with Pioglitazone provides better glycemic control than Biphasic Insulin Aspart 30 monotherapy or Pioglitazone/Sulfonylurea combination
Raz, I
Stranks, S
Filipczak, R
Joshi, P
Lertoft, B
Råstam, J
Chow, F
[J]. DIABETES, 2003, 52 : A453 - A454
[2] In patients with poorly controlled Type 2 diabetes, biphasic insulin aspart 30 combined with metformin provides better glycaemic control than sulphonylurea/metformin combination
Kvapil, M
Mikolajczyk-Swatko, A
Ostergaard, AH
Shestakova, M
[J]. DIABETOLOGIA, 2002, 45 : A18 - A18
[3] GLYCAEMIC CONTROL AND INSULIN UTILIZATION IN UK PATIENTS WITH TYPE 2 DIABETES INITIATED ON EITHER BIPHASIC INSULIN ASPART 30 OR BIPHASIC HUMAN INSULIN 30
Fakhoury, W.
Richter, H.
Christensen, T.
Thomsen, T. L.
Irwin, D.
Anderson, P.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A55 - A55
[4] Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes
M. Velojic-Golubovic
D. Mikic
M. Pesic
D. Dimic
S. Radenkovic
S. Antic
[J]. Journal of Endocrinological Investigation, 2009, 32 : 23 - 27
[5] Biphasic insulin aspart 30: Better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes
Velojic-Golubovic, M.
Mikic, D.
Pesic, M.
Dimic, D.
Radenkovic, S.
Antic, S.
[J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (01) : 23 - 27
[6] Biphasic insulin aspart 30 combined with metformin provides better glycemic control in poorly controlled type 2 diabetic patients
Kvapil, M
Mikolajczyk-Swatko, A
Ostergaard, AH
Shestakova, M
[J]. DIABETES, 2002, 51 : A104 - A105
[7] Biphasic Insulin Aspart 30 (BIAsp 30) is Safe and Improves Glycaemic Control in Insulin Naive Patients with Type 2 Diabetes
Esteghamati, Alireza
Nakhjavani, Manouchehr
Aminorroaya, Ashraf
Aboutorabi, Robabeh
Niafar, Mitra
Mohammadi, Mohammad
Parvaresh, Ehsan
[J]. JOURNAL OF DIABETES & METABOLISM, 2011, 2 (03)
[8] Effect of biphasic insulin aspart 30 combined with metformin on glycaemic control in obese people with type 2 diabetes
Ascic-Buturovic, Belma
[J]. BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2007, 7 (04) : 335 - 338
[9] Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
Kvapil, A
Swatko, A
Hilberg, C
Shestakova, A
[J]. DIABETES OBESITY & METABOLISM, 2006, 8 (01): : 39 - 48
[10] Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy
Raz, I
Mouritzen, U
Vaz, J
Hershkovitz, T
Wainstein, J
Harman-Boehm, I
[J]. CLINICAL THERAPEUTICS, 2003, 25 (12) : 3109 - 3123

← 1 2 3 4 5 →